If I would be kind of a little bit worse physician, couldn't, or maybe just a medical writer or an assistant, or maybe even some kind of AI agent, could that AI solution do everything around a clinical study?

Well, potentially it could in some senses.

So I think the technologies today, particularly when we look at agentic AI, which is the most recent development, which allows for specialization.

So effectively, we can think of an agent within an AI space as being a large language model, such as GPT, which has been specifically trained on one area of expertise, whether it be market heading modeling or biomarkers or whatever.

And if we were to do that, we could probably generate all of the documents that you've mentioned there.

And initially, they may look quite plausible.

Yeah, they may look quite good.

But could we actually optimize things if we also include aspects of the phase 1b study into it? Or what kind of implications would that have for the phase 2 study? Can we optimize the whole thing a little bit differently so that we get better through the phase 2 study and then maybe safe in the phase 2 study? There's so many different aspects that I think it's really, really difficult to just get out of AI.